Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email email@example.com.
Check back regularly for news, coverage, and announcements about MAVA.
Square 1 Bank, the premier banking partner to entrepreneurs and the venture capital community, announced that it has acquired substantially all of the assets and hired all employees of Sand Hill Finance, LLC.
Acura Pharmaceuticals, Inc. ACUR entered into a Loan and Security Agreement with Oxford Finance LLC, pursuant to which Oxford agreed to make a term loan to the Company in the principal amount of $10.0 million.
Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, has completed a $25 million long-term debt financing with a lending syndicate consisting of MidCap Financial, LLC, Oxford Finance LLC, and Silicon Valley Bank.
Boulder Ventures Ltd. has raised $100 million for a new fund, and Crestone Capital Advisors LLC has raised $7 million for two new funds, according to documents filed with the Securities and Exchange Commission.
Acentia CEO Todd Stottlemyer has introduced three new officials with at least four decades of combined experience for the company’s business development unit.
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it has entered into a new amended and restated credit facility with Hercules Technology Growth Capital, Inc.
iJET International, Inc. (iJET), a leading operational risk management solutions provider, today announced the completion of an investment by private equity firm LLR Partners.
Cloud computing firm Huddle knows the perks of being backed by the CIA’s nonprofit investment arm, In-Q-Tel.
A pair of local venture capital firms, Owings Mills-based Greenspring Associates and Chevy Chase-based New Enterprise Associates (NEA), have taken part in a $50 million round of funding for San Francisco-based CloudFlare.
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced that CTI has received the remaining $5 million from Hercules Technology Growth Capital, Inc. (NYSE: HTGC) available under the existing loan agreement that was established in March 2013.